
Glimipack M 2mg/500mg Tablet
Marketer
Koye Pharmaceuticals Pvt ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Overview Glimipack M 2mg/500mg Tablet
Diabetam Duo 2mg/500mg tablets are classified as antidiabetic medications, combining two active agents to manage type 2 diabetes in adults. This formulation helps regulate blood glucose levels. Diabetam Duo should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan, including a balanced diet, regular physical activity, and weight management as recommended by your doctor. Lifestyle modifications are essential for effective diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to treat them promptly. Maintain regular mealtimes and carry a readily available source of fast-acting glucose (e.g., sugary snacks or juice). Alcohol consumption should be minimized due to increased hypoglycemia risk. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring is necessary, and your physician may order blood tests to check blood cell counts and liver function.
Uses of Glimipack M 2mg/500mg Tablet
Managing type 2 diabetes
Major Benefits of Glimipack M 2mg/500mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimipack M 2mg/500mg Tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with a meal.
Common Side effects of Glimipack M 2mg/500mg Tablet:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glimipack M 2mg/500mg Tablet:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimipack M 2mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.
How Glimipack M 2mg/500mg Tablet works:
Glimepiride/Metformin 2mg/500mg tablets (Glimipack M) combine two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Glimipack M 2mg/500mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glimipack M 2mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Lactation and the use of Glimipack M 2mg/500mg tablets are incompatible. Evidence indicates potential infant harm from this medication.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if these conditions arise.
KidneyCAUTION
Individuals with kidney impairment should use Glimipack M 2mg/500mg tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. The medication is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Glimipack M 2mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is recommended. For individuals with mild to moderate liver disease, initiation should involve a low Glimipack M 2mg/500mg tablet dose; however, its use is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Glimipack M 2mg/500mg Tablet :
Should you forget a Glimipack M 2mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimipack M 2mg/500mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
